Loading clinical trials...
Loading clinical trials...
The quality of primary healthcare systems for patients with hypertension (HTA) in Morocco is a critical issue due to its high prevalence and significant impact on morbidity and mortality. The concept ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Moroccan Society of Cardiology
Collaborators
NCT07481981 · Pulmonary Arterial Hypertension
NCT07218029 · Pulmonary Arterial Hypertension
NCT07365332 · Pulmonary Arterial Hypertension
NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension
NCT06549452 · Pulmonary Arterial Hypertension
Moroccan Society of Cardiology
Meknes, Morocco
Moroccan Society of Cardiology
Casablanca
UM6SSP
Casablanca
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions